Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ]: Market Wire
Financial Statement 10/11
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ]: Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011
Fri, October 7, 2011
Thu, October 6, 2011
Wed, October 5, 2011
Tue, October 4, 2011
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ]: Market Wire
Medwell Capital to Adopt IFRS
Sun, October 2, 2011
Sat, October 1, 2011
Fri, September 30, 2011
Thu, September 29, 2011
Wed, September 28, 2011
Tue, September 27, 2011
Mon, September 26, 2011
Sat, September 24, 2011
Fri, September 23, 2011
Thu, September 22, 2011

Expert's Economic Outlook, Global - Equity Research on Impax Laboratories Inc and Enzo Biochem, Inc.

  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. impax-laboratories-inc-and-enzo-biochem-inc.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

October 07, 2011 09:00 ET

Expert's Economic Outlook, Global - Equity Research on Impax Laboratories Inc and Enzo Biochem, Inc.

MACAU--(Marketwire - Oct 7, 2011) - Today, [ www.EquityMarketsInc.com ] announced its research report highlighting Impax Laboratories Inc (NASDAQ: [ IPXL ]) and Enzo Biochem, Inc. (NYSE: [ ENZ ]). Full content and research is available at [ www.EquityMarketsInc.com/research.php?id=IPXL+ENZ ].

Short-term outlooks within US and global economies continue to adjust downward, as US Treasury yields touched their lowest levels in over 65 years. International Monetary Fund downgraded estimates for US growth by 1.0% this year, down from 2.5%. 'Significant downside risks' to the US economy were confirmed by the Federal Reserve pressured by 'strains in global financial markets.'

As the US dollar trades above an eight-month high against the Euro, it highlights a deepening of the Eurozone sovereign debt crisis -- furthered by continued policy inaction from European governments. We expect continued volatility until economic data stabilizes and we see decisive policy action to deal with the Eurozone debt crisis.

Our members are preparing for a turn in tides. Currently, the Credit Suisse Risk Appetite Indicator is at a 30-year low. For the past three occurrences, this level has acted as a leading indicator of large stock market rallies 18 months following.

Equity Markets has reviewed Impax Laboratories Inc for its current position within the healthcare industry. Impax Laboratories, Inc. (Impax) is a technology-based, specialty pharmaceutical company applying formulation and development expertise, as well as its drug delivery technology, to the development, manufacture and marketing of bioequivalent pharmaceutical products. The full research report on Impax Laboratories Inc (NASDAQ: [ IPXL ]) is available here: [ www.EquityMarketsInc.com/research.php?id=IPXL ].

Equity Markets has reviewed Enzo Biochem, Inc. for its development within the healthcare industry. Enzo Biochem, Inc. (Enzo) is an integrated life sciences and biotechnology company focused on harnessing biological processes to develop research tools, diagnostics and therapeutics and serves as a provider of test services, including esoteric tests, to the medical community. The full research report on Enzo Biochem, Inc. (NYSE: [ ENZ ]) is available here: [ www.EquityMarketsInc.com/research.php?id=ENZ ].

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.